Japan Hospice Holdings Inc.
7061・Growth Market・Services
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 5 directors (including 3 outside directors, an outside ratio of 60%). During the fiscal year under review, the Board of Directors met 16 times, with all directors and corporate auditors attending every meeting. 3 corporate auditors (including 2 outside corporate auditors: a certified public accountant and an attorney) are responsible for management oversight. The establishment of a Nomination Committee or Compensation Committee has not been confirmed.
Risk Management
The Company has established Risk Management Regulations and set up a Risk Management Committee to comprehensively and holistically manage risks across the group. Each department head conducts investigations and audits, and a system is in place whereby results are reported periodically to the Board of Directors and the Board of Corporate Auditors. A framework has also been built whereby the risk assessment results of operating subsidiaries are reported to the parent company's Board of Directors.
Shareholder Returns
The full-year dividend forecast for FY2026 (ending December 2026) is ¥25 per share (year-end lump sum), maintaining the same amount as the previous period's actual result. No change to the dividend forecast. No mention of share buybacks.
Dividend Policy
The policy is to implement dividends while emphasizing upfront investment for business expansion and building up internal reserves, taking into account the financial position and business performance. The basic policy is a single year-end dividend paid once per year. The actual result for FY2025 (ending December 2025) was ¥25 per share (¥0 at second-quarter end, ¥25 at year-end). The forecast for FY2026 (ending December 2026) is ¥25 per share (¥0 at second-quarter end, ¥25 at year-end), with no revision from the most recently announced forecast.
ESG
The Company has not yet formulated a basic sustainability policy, but positions the resolution of social issues through the dissemination and promotion of hospices at the core of its business. In terms of human capital, the Company has achieved a female worker ratio of 71.4% among management positions (target: to further raise the ratio beyond 70%) and a 100% rate of childcare leave uptake among male employees. The Company is also focusing on nurse development through specialized educational programs such as ELNEC-J.
Last updated: March 25, 2026